PFA Pension Forsikringsaktieselskab Invests $43.39 Million in GE HealthCare Technologies Inc. $GEHC

Key Points

• PFA Pension Forsikringsaktieselskab opened a new position in GE HealthCare, buying 520,754 shares worth about $43.39 million, representing roughly 0.11% of the company at quarter‑end.
• Company insiders including CEO Peter Arduini and director Frank R. Jimenez have been buying shares recently (9,229 shares acquired over the last 90 days), signaling management confidence despite the broader sell‑side caution.
• GE HealthCare trimmed FY‑2026 EPS guidance to $4.80–$5.00 after a Q1 EPS miss ($0.99 vs. $1.07 est.) despite a revenue beat, prompting analyst price‑target cuts and a consensus rating of "Hold" (avg. target ~$80.67).

PFA Pension Forsikringsaktieselskab purchased a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 520,754 shares of the company's stock, valued at approximately $43,394,000. PFA Pension Forsikringsaktieselskab owned approximately 0.11% of GE HealthCare Technologies at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. E Fund Management Hong Kong Co. Ltd. grew its position in shares of GE HealthCare Technologies by 130.7% during the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company's stock worth $26,000 after buying an additional 196 shares in the last quarter. Godsey & Gibb Inc. bought a new position in shares of GE HealthCare Technologies during the 3rd quarter worth $26,000. Laurel Wealth Advisors LLC bought a new position in shares of GE HealthCare Technologies during the 4th quarter worth $26,000. Optima Capital LLC bought a new position in shares of GE HealthCare Technologies during the 4th quarter worth $27,000. Finally, Maseco LLP bought a new position in shares of GE HealthCare Technologies during the 4th quarter worth $29,000. Institutional investors own 82.06% of the company's stock.

Insiders Place Their Bets

In other GE HealthCare Technologies news, insider Frank R. Jimenez purchased 1,750 shares of the stock in a transaction on Thursday, April 30th. The stock was acquired at an average price of $60.45 per share, with a total value of $105,787.50. Following the completion of the acquisition, the insider owned 93,932 shares in the company, valued at $5,678,189.40. The trade was a 1.90% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Peter J. Arduini purchased 4,169 shares of the stock in a transaction on Thursday, April 30th. The stock was acquired at an average cost of $59.92 per share, with a total value of $249,806.48. Following the acquisition, the chief executive officer owned 259,424 shares of the company's stock, valued at approximately $15,544,686.08. This represents a 1.63% increase in their position. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders acquired 9,229 shares of company stock valued at $556,180. 0.36% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

GEHC has been the topic of a number of recent research reports. JPMorgan Chase & Co. dropped their price target on GE HealthCare Technologies from $80.00 to $65.00 and set a "neutral" rating on the stock in a research report on Thursday. Mizuho decreased their price objective on GE HealthCare Technologies from $95.00 to $90.00 and set an "outperform" rating for the company in a research note on Monday, April 13th. UBS Group downgraded GE HealthCare Technologies from a "neutral" rating to a "sell" rating and raised their price objective for the company from $73.00 to $77.00 in a research report on Thursday, January 15th. Citigroup dropped their price objective on GE HealthCare Technologies from $80.00 to $65.00 and set a "neutral" rating on the stock in a research report on Thursday. Finally, Barclays dropped their price objective on GE HealthCare Technologies from $87.00 to $78.00 and set an "equal weight" rating on the stock in a research report on Thursday. Eight investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of "Hold" and a consensus target price of $80.67.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $61.03 on Friday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.13 and a current ratio of 1.22. The company has a market cap of $27.76 billion, a PE ratio of 14.60, a P/E/G ratio of 1.39 and a beta of 0.75. The business has a 50-day simple moving average of $73.28 and a two-hundred day simple moving average of $77.56. GE HealthCare Technologies Inc. has a fifty-two week low of $58.75 and a fifty-two week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). The business had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.GE HealthCare Technologies's revenue was up 7.4% compared to the same quarter last year. During the same period in the prior year, the business posted $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities analysts expect that GE HealthCare Technologies Inc. will post 4.88 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 3.35%.

GE HealthCare Technologies News Summary

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Insiders are buying shares — CEO Peter Arduini, CFO James Saccaro and director Frank R. Jimenez increased positions (multiple Form 4 filings), which investors often interpret as management confidence in the company’s outlook. Read More. • Read More. • Read More.
• Positive Sentiment: Heavy call-option buying — an unusual surge in call volume suggests short-term bullish/speculative interest that can amplify upside moves. (No article link available)
• Neutral Sentiment: Wells Fargo lowered its price target to $75 but kept an overweight rating, signaling upside exists vs. current levels while tempering near-term expectations. Read More.
• Neutral Sentiment: Operational changes — GEHC announced a reorganization (Imaging + Advanced Visualization) and executive moves intended to improve execution; benefits could take multiple quarters to materialize. Read More.
• Negative Sentiment: Guidance cut and margin pressure — management trimmed FY26 EPS guidance to $4.80–5.00, citing inflation, higher component and freight costs and supply issues; this is the core reason for recent downside pressure. Read More.
• Negative Sentiment: Mixed Q1 results — revenue beat (~$5.13B) but EPS missed ($0.99 vs. $1.07 est.) and margins compressed, reinforcing short‑term risk to earnings. Read More.
• Negative Sentiment: Analyst downgrades / price‑target cuts — Citigroup, JPMorgan and others trimmed targets and ratings (e.g., PTs cut to ~$65–75), pulling sell‑side support lower and contributing to volatility. Read More.
• Negative Sentiment: Investor litigation inquiry — a Johnson Fistel investigation adds headline and legal risk that could increase volatility. Read More.

About GE HealthCare Technologies

GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.